It's already stated (in the Zacks report) that POET is looking to raise 20-30M on the Nasdaq to fund the development of the spectrometer by leveraging the OI platform. I expect POET to announce some kind of partnership/JV related to this vertical (health/wearables) before the uplisting. Remember, this isn't just about trading on the Nasdaq, it's also a capital raise to fuel POET's growth in the health tech vertical.